Tage Astrup

8.0k total citations · 1 hit paper
180 papers, 5.6k citations indexed

About

Tage Astrup is a scholar working on Cancer Research, Biotechnology and Hematology. According to data from OpenAlex, Tage Astrup has authored 180 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cancer Research, 51 papers in Biotechnology and 49 papers in Hematology. Recurrent topics in Tage Astrup's work include Protease and Inhibitor Mechanisms (54 papers), Enzyme Production and Characterization (51 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Tage Astrup is often cited by papers focused on Protease and Inhibitor Mechanisms (54 papers), Enzyme Production and Characterization (51 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Tage Astrup collaborates with scholars based in Denmark, United States and India. Tage Astrup's co-authors include S. Müllertz, Pieter Brakman, Hau C. Kwaan, O Albrechtsen, Sixtus Thorsen, Jørgen Jespersen, Steffen Ullitz Thorsen, Salvatore Camiolo, Pia Glas-Greenwalt and Douglas R. Rosing and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Tage Astrup

176 papers receiving 4.6k citations

Hit Papers

The fibrin plate method for estimating fibrinolytic activity 1952 2026 1976 2001 1952 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tage Astrup Denmark 35 1.9k 1.8k 1.7k 1.2k 1.1k 180 5.6k
Aaron Janoff United States 44 310 0.2× 1.5k 0.8× 581 0.3× 1.8k 1.5× 2.0k 1.9× 128 6.7k
Toshihiko Terao Japan 43 210 0.1× 1.2k 0.7× 876 0.5× 613 0.5× 1.6k 1.5× 220 5.8k
Julian L. Ambrus United States 33 184 0.1× 397 0.2× 619 0.4× 523 0.4× 733 0.7× 287 4.5k
Friedrich Kueppers United States 32 157 0.1× 871 0.5× 473 0.3× 932 0.8× 831 0.8× 127 3.2k
John S. Bomalaski United States 37 1.8k 0.9× 1.3k 0.7× 160 0.1× 429 0.4× 1.8k 1.7× 132 4.8k
Hans Prydz Norway 44 92 0.0× 632 0.4× 2.1k 1.2× 714 0.6× 3.2k 3.1× 205 7.1k
Lars C. Petersen Denmark 31 128 0.1× 737 0.4× 2.0k 1.2× 456 0.4× 951 0.9× 93 3.6k
Anthony M. Jevnikar Canada 50 710 0.4× 387 0.2× 246 0.1× 372 0.3× 2.4k 2.3× 209 8.2k
Carl G. Becker United States 17 67 0.0× 892 0.5× 1.1k 0.6× 660 0.6× 2.7k 2.5× 27 7.0k
Samuel I. Rapaport United States 46 137 0.1× 249 0.1× 5.1k 2.9× 1.5k 1.2× 650 0.6× 133 8.0k

Countries citing papers authored by Tage Astrup

Since Specialization
Citations

This map shows the geographic impact of Tage Astrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tage Astrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tage Astrup more than expected).

Fields of papers citing papers by Tage Astrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tage Astrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tage Astrup. The network helps show where Tage Astrup may publish in the future.

Co-authorship network of co-authors of Tage Astrup

This figure shows the co-authorship network connecting the top 25 collaborators of Tage Astrup. A scholar is included among the top collaborators of Tage Astrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tage Astrup. Tage Astrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Astrup, Tage. (1991). Fibrinolysis: Past and Present, a Reflection of Fifty Years. Seminars in Thrombosis and Hemostasis. 17(3). 161–174. 23 indexed citations
2.
Astrup, Tage & Jørgen Jespersen. (1984). Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.. PubMed. 111(4). 407–15. 2 indexed citations
3.
Astrup, Tage & Jørgen Jespersen. (1984). Thrombosis, disseminated intravasclar coagulation, and the dynamic haemostatic balance. Aspects of prophylaxis and treatment. International Angiology. 3(4). 331–342. 3 indexed citations
4.
Astrup, Tage, et al.. (1973). Failure to substantiate a low molecular weight inhibitor of fibrinolysis in blood.. PubMed. 243(123). 51–51. 1 indexed citations
5.
Astrup, Tage, et al.. (1972). THE HISTOCHEMICAL STUDY OF THE FIBRINOLYTIC ACTIVITY. The Japanese Journal of Urology. 63(6). 387–396. 1 indexed citations
6.
Astrup, Tage, et al.. (1972). Fibrinolytic activity in injured rat skin. Experimental and Molecular Pathology. 16(2). 101–108. 11 indexed citations
7.
Glas-Greenwalt, Pia, Fritz Karl Beller, & Tage Astrup. (1971). Comparative assays of tissue plasminogen activator in myometrium, cervix, and fibromyomas of the human uterus. American Journal of Obstetrics and Gynecology. 110(5). 721–725. 11 indexed citations
8.
Rosing, Douglas R., Pieter Brakman, David R. Redwood, et al.. (1970). Blood Fibrinolytic Activity in Man. Circulation Research. 27(2). 171–184. 181 indexed citations
9.
Astrup, Tage, et al.. (1966). Blood Coagulation and Plasma Fibrinolysis in Geriatric Patients with Decreased Liver Function. Acta Medica Scandinavica. 179(1). 101–111. 5 indexed citations
10.
Astrup, Tage, et al.. (1966). Effects of preparations of heparin and heparitin sulfate on fibrinolysis. Archives of Biochemistry and Biophysics. 113(3). 634–640. 6 indexed citations
11.
Brakman, Pieter & Tage Astrup. (1964). EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD. The Lancet. 284(7349). 10–12. 31 indexed citations
12.
Astrup, Tage, et al.. (1964). AORTIC ARTERIOSCLEROSIS IN RABBITS. FED INHIBITORS OF FIBRINOLYSIS.. PubMed. 78. 474–82. 5 indexed citations
13.
Astrup, Tage, et al.. (1961). Estimation of Thromboplastin Activation in Plasma. Scandinavian Journal of Clinical and Laboratory Investigation. 13(3). 377–389. 20 indexed citations
14.
Astrup, Tage, et al.. (1960). The Fibrinolytic System in Human Blood, as Exemplified in a Case of Agammaglobulinemia and a Case of Macroglobulinemia. Scandinavian Journal of Clinical and Laboratory Investigation. 12(3). 336–341. 15 indexed citations
15.
Astrup, Tage, et al.. (1959). Thromboplastic and Fibrinolytic Activity of the Human Aorta. Circulation Research. 7(6). 969–976. 58 indexed citations
16.
Roberts, Harold R. & Tage Astrup. (1957). Content of Tissue Activator of Plasminogen in Monkey Tissues. Thrombosis and Haemostasis. 1(03/04). 376–379. 15 indexed citations
17.
Astrup, Tage, et al.. (1957). Defects in blood coagulation.. PubMed. 4(5). 164–8. 2 indexed citations
18.
Astrup, Tage, Kurt G. Schilling, A. Birch‐Andersen, & E. H. Olsen. (1954). Fractional Precipitation of Serum Proteins by Heavy Metal Ions.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 8. 1361–1367. 1 indexed citations
19.
Astrup, Tage & S. Müllertz. (1952). The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry and Biophysics. 40(2). 346–351. 1442 indexed citations breakdown →
20.
Astrup, Tage, et al.. (1951). Free Amino Acids in Mammalian Tissue. Acta Physiologica Scandinavica. 24(2-3). 202–211. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026